Constance Delaugerre

12.8k total citations
206 papers, 4.3k citations indexed

About

Constance Delaugerre is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Constance Delaugerre has authored 206 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 163 papers in Infectious Diseases, 131 papers in Virology and 67 papers in Epidemiology. Recurrent topics in Constance Delaugerre's work include HIV Research and Treatment (131 papers), HIV/AIDS drug development and treatment (114 papers) and HIV/AIDS Research and Interventions (91 papers). Constance Delaugerre is often cited by papers focused on HIV Research and Treatment (131 papers), HIV/AIDS drug development and treatment (114 papers) and HIV/AIDS Research and Interventions (91 papers). Constance Delaugerre collaborates with scholars based in France, United States and Ivory Coast. Constance Delaugerre's co-authors include Jean‐Michel Molina, Vincent Cálvez, Christine Katlama, Marie‐Laure Chaix, Christine Rouzioux, Sarah Maylin, Anne‐Geneviève Marcelin, François Simon, Jade Ghosn and Gilles Peytavin and has published in prestigious journals such as The Lancet, The Journal of Experimental Medicine and SHILAP Revista de lepidopterología.

In The Last Decade

Constance Delaugerre

199 papers receiving 4.2k citations

Peers

Constance Delaugerre
Carmen de Mendoza Spain
Ralph DeMasi United States
Michael S Saag United States
Suzanne Jurriaans Netherlands
Anna María Geretti United Kingdom
Neil Parkin United States
Christophe Pasquier France
Lisa M. Demeter United States
Marie‐Laure Chaix France
Bluma Brenner Canada
Carmen de Mendoza Spain
Constance Delaugerre
Citations per year, relative to Constance Delaugerre Constance Delaugerre (= 1×) peers Carmen de Mendoza

Countries citing papers authored by Constance Delaugerre

Since Specialization
Citations

This map shows the geographic impact of Constance Delaugerre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Constance Delaugerre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Constance Delaugerre more than expected).

Fields of papers citing papers by Constance Delaugerre

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Constance Delaugerre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Constance Delaugerre. The network helps show where Constance Delaugerre may publish in the future.

Co-authorship network of co-authors of Constance Delaugerre

This figure shows the co-authorship network connecting the top 25 collaborators of Constance Delaugerre. A scholar is included among the top collaborators of Constance Delaugerre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Constance Delaugerre. Constance Delaugerre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chevalier, Mathieu F., Vincent Allain, Julien Gras, et al.. (2025). Donor HLA-DQ genetic and functional divergence affect the control of BK polyoma virus infection after kidney transplantation. Science Advances. 11(10). eadt3499–eadt3499. 1 indexed citations
2.
Mellon, Guillaume, Nadia Mahjoub, Fabien Métivier, et al.. (2025). Enhancing the control of respiratory virus spread: a comprehensive approach integrating airborne virus detection, aerological investigations, and airflow modeling for practical implementation. Infection Control and Hospital Epidemiology. 46(3). 256–265. 1 indexed citations
3.
Schnepf, Nathalie, Nadia Mahjoub, Aliénor Xhaard, et al.. (2024). Prospective comparison of cytomegalovirus quantification in whole blood and plasma samples among hematopoietic stem cell transplant and kidney transplant recipients. Journal of Clinical Virology. 174. 105690–105690.
4.
Coelho, Lara E., Corine Chazallon, Didier Laureillard, et al.. (2024). Incidence and Predictors of Tuberculosis-associated IRIS in People With HIV Treated for Tuberculosis: Findings From Reflate TB2 Randomized Trial. Open Forum Infectious Diseases. 11(3). ofae035–ofae035. 2 indexed citations
5.
Chaix, Marie‐Laure, Karl Stéfic, Caroline Lascoux‐Combe, et al.. (2024). Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV‐1 infected patients in 2020–2023. Journal of Medical Virology. 96(10). e29948–e29948. 3 indexed citations
6.
Gras, Julien, M.N. Peraldi, Lucie Bonnet‐Madin, et al.. (2023). BK virus genotypes and humoral response in kidney transplant recipients with BKV associated nephropathy. Transplant Infectious Disease. 25(2). e14012–e14012. 6 indexed citations
7.
Nel, Isabelle, Marina Charbit, Véronique Baudouin, et al.. (2023). Optimizing COVID-19 Vaccination Strategy in Pediatric Kidney Transplant Recipients: Humoral and Cellular Response to SARS-CoV-2 mRNA Vaccination. Transplant International. 36. 3 indexed citations
8.
Cuffel, Alexis, Sarah Maylin, Hélène Le Buanec, et al.. (2022). Humoral and cellular responses to SARS-CoV-2 BNT162b2 vaccination in allogeneic hematopoietic stem cell transplantation recipients. Vaccine. 40(33). 4682–4685. 6 indexed citations
9.
Castro, Nathalie De, Kévin Jean, Rodrigo Escada, et al.. (2022). Determinants of Antiretroviral Treatment Success and Adherence in People With Human Immunodeficiency Virus Treated for Tuberculosis. Open Forum Infectious Diseases. 9(12). ofac628–ofac628. 2 indexed citations
10.
Pourcelot, Marie, Beate M. Kümmerer, Sarah Gallois‐Montbrun, et al.. (2022). RACK1 Associates with RNA-Binding Proteins Vigilin and SERBP1 to Facilitate Dengue Virus Replication. Journal of Virology. 96(7). e0196221–e0196221. 25 indexed citations
11.
Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Persistent HBV replication and serological response during up to 15 years of tenofovir-based antiretroviral therapy in HIV/HBV-coinfected patients: a multicentre prospective cohort study. Journal of Antimicrobial Chemotherapy. 76(11). 3009–3019. 4 indexed citations
12.
Onodi, Fanny, Lucie Bonnet‐Madin, Laurent Meertens, et al.. (2021). SARS-CoV-2 induces human plasmacytoid predendritic cell diversification via UNC93B and IRAK4. The Journal of Experimental Medicine. 218(4). 80 indexed citations
13.
Miailhes, Patrick, Caroline Lascoux‐Combe, Sarah Maylin, et al.. (2021). Effect of Viral Replication and Liver Fibrosis on All-Cause Mortality in Human Immunodeficiency Virus–Hepatitis B Virus–Coinfected Individuals: A Retrospective Analysis of a 15-Year Longitudinal Cohort. Clinical Infectious Diseases. 74(6). 1012–1021. 4 indexed citations
14.
Covington, Michael F., Guy Aidelberg, Tamara Matúte, et al.. (2021). Accessible LAMP-Enabled Rapid Test (ALERT) for Detecting SARS-CoV-2. Viruses. 13(5). 742–742. 19 indexed citations
15.
Ghosn, Jade, Lambert Assoumou, Caroline Lascoux‐Combe, et al.. (2021). HIV-1 RNA Kinetics in Blood Plasma and in Seminal Plasma of Men Starting a Dolutegravir-Based Triple-Combination Regimen at the Time of Primary HIV-1 Infection. The Journal of Infectious Diseases. 225(1). 116–120. 4 indexed citations
16.
Molina, Jean‐Michel, Jade Ghosn, Constance Delaugerre, et al.. (2021). Incidence of HIV infection with daily or on-demand oral prep with TDF/FTC in france. 29(1). 43–44. 8 indexed citations
17.
LeGoff, Jérôme, Solen Kernéis, Caroline Elie, et al.. (2021). Evaluation of a saliva molecular point of care for the detection of SARS-CoV-2 in ambulatory care. Scientific Reports. 11(1). 21126–21126. 16 indexed citations
18.
19.
Delaugerre, Constance. (2010). Barrière génétique à la résistance des antirétroviraux : Le point sur le raltégravir, premier inhibiteur d’intégrase. Médecine et Maladies Infectieuses. 40(1). 5 indexed citations
20.
Delaugerre, Constance & Marie‐Laure Chaix. (2006). Résistance du VIH aux inhibiteurs non nucléosidiques de la transcriptase inverse (INNTI). Virologie. 10(4). 255–266. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Carmen de Mendoza Breakdown of academic impact, for papers by Ralph DeMasi Breakdown of academic impact, for papers by Michael S Saag Breakdown of academic impact, for papers by Suzanne Jurriaans Breakdown of academic impact, for papers by Anna María Geretti Breakdown of academic impact, for papers by Neil Parkin Breakdown of academic impact, for papers by Christophe Pasquier Breakdown of academic impact, for papers by Lisa M. Demeter Breakdown of academic impact, for papers by Marie‐Laure Chaix Breakdown of academic impact, for papers by Bluma Brenner
Rankless by CCL
2026